BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15536154)

  • 1. Gonadotropin-releasing hormone antagonist cetrorelix down-regulates proliferating cell nuclear antigen and epidermal growth factor expression and up-regulates apoptosis in association with enhanced poly(adenosine 5'-diphosphate-ribose) polymerase expression in cultured human leiomyoma cells.
    Chen W; Yoshida S; Ohara N; Matsuo H; Morizane M; Maruo T
    J Clin Endocrinol Metab; 2005 Feb; 90(2):884-92. PubMed ID: 15536154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone receptor modulator CDB-2914 down-regulates proliferative cell nuclear antigen and Bcl-2 protein expression and up-regulates caspase-3 and poly(adenosine 5'-diphosphate-ribose) polymerase expression in cultured human uterine leiomyoma cells.
    Xu Q; Takekida S; Ohara N; Chen W; Sitruk-Ware R; Johansson ED; Maruo T
    J Clin Endocrinol Metab; 2005 Feb; 90(2):953-61. PubMed ID: 15572421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation by IGF-I of proliferating cell nuclear antigen and Bcl-2 protein expression in human uterine leiomyoma cells.
    Gao Z; Matsuo H; Wang Y; Nakago S; Maruo T
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5593-9. PubMed ID: 11701740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of heparin-binding epidermal growth factor-like growth factor on the growth of cultured human uterine leiomyoma cells and myometrial cells.
    Wang J; Ohara N; Takekida S; Xu Q; Maruo T
    Hum Reprod; 2005 Jun; 20(6):1456-65. PubMed ID: 15760954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of proliferation and up-regulation of apoptosis by gonadotropin-releasing hormone agonist in cultured uterine leiomyoma cells.
    Wang Y; Matsuo H; Kurachi O; Maruo T
    Eur J Endocrinol; 2002 Mar; 146(3):447-56. PubMed ID: 11888853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel selective progesterone receptor modulator asoprisnil (J867) inhibits proliferation and induces apoptosis in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells.
    Chen W; Ohara N; Wang J; Xu Q; Liu J; Morikawa A; Sasaki H; Yoshida S; Demanno DA; Chwalisz K; Maruo T
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1296-304. PubMed ID: 16464945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of SPRM asoprisnil (J867) on proliferation, apoptosis, and the expression of growth factors in cultured uterine leiomyoma cells and normal myometrial cells.
    Ohara N; Morikawa A; Chen W; Wang J; DeManno DA; Chwalisz K; Maruo T
    Reprod Sci; 2007 Dec; 14(8 Suppl):20-7. PubMed ID: 18089606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma.
    Shimomura Y; Matsuo H; Samoto T; Maruo T
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2192-8. PubMed ID: 9626159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin-releasing hormone (GnRH) agonist leuprolide acetate and GnRH antagonist cetrorelix acetate directly inhibit leiomyoma extracellular matrix production.
    Britten JL; Malik M; Levy G; Mendoza M; Catherino WH
    Fertil Steril; 2012 Nov; 98(5):1299-307. PubMed ID: 22901846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective progesterone receptor modulator asoprisnil induces endoplasmic reticulum stress in cultured human uterine leiomyoma cells.
    Xu Q; Ohara N; Liu J; Nakabayashi K; DeManno D; Chwalisz K; Yoshida S; Maruo T
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1002-11. PubMed ID: 17652152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luteinizing hormone-releasing hormone agonist triptorelin and antagonist cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers.
    Gründker C; Völker P; Schulz KD; Emons G
    Gynecol Oncol; 2000 Aug; 78(2):194-202. PubMed ID: 10926802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular mechanisms of growth inhibition of human epithelial ovarian cancer cell line by LH-releasing hormone antagonist Cetrorelix.
    Tang X; Yano T; Osuga Y; Matsumi H; Yano N; Xu J; Wada O; Koga K; Kugu K; Tsutsumi O; Schally AV; Taketani Y
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3721-7. PubMed ID: 12161501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentration-dependent effects of a selective estrogen receptor modulator raloxifene on proliferation and apoptosis in human uterine leiomyoma cells cultured in vitro.
    Liu J; Matsuo H; Xu Q; Chen W; Wang J; Maruo T
    Hum Reprod; 2007 May; 22(5):1253-9. PubMed ID: 17220163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.
    Yun BS; Seong SJ; Cha DH; Kim JY; Kim ML; Shim JY; Park JE
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():62-7. PubMed ID: 26093349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone down-regulates insulin-like growth factor-I expression in cultured human uterine leiomyoma cells.
    Yamada T; Nakago S; Kurachi O; Wang J; Takekida S; Matsuo H; Maruo T
    Hum Reprod; 2004 Apr; 19(4):815-21. PubMed ID: 15033949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel selective progesterone receptor modulator asoprisnil activates tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated signaling pathway in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells.
    Sasaki H; Ohara N; Xu Q; Wang J; DeManno DA; Chwalisz K; Yoshida S; Maruo T
    J Clin Endocrinol Metab; 2007 Feb; 92(2):616-23. PubMed ID: 17105846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant H2 relaxin inhibits apoptosis and induces cell proliferation in cultured leiomyoma cells without affecting those in cultured normal myometrial cells.
    Suzuki K; Nakabayashi K; Yamada AY; Lodhi RS; Hazama R; Ebina Y; Yamada H
    Fertil Steril; 2012 Mar; 97(3):734-41. PubMed ID: 22226177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGFbeta3 and their receptors in cultured uterine leiomyoma cells.
    Wang J; Ohara N; Wang Z; Chen W; Morikawa A; Sasaki H; DeManno DA; Chwalisz K; Maruo T
    Hum Reprod; 2006 Jul; 21(7):1869-77. PubMed ID: 16613890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular bases for the actions of ovarian sex steroids in the regulation of proliferation and apoptosis of human uterine leiomyoma.
    Matsuo H; Kurachi O; Shimomura Y; Samoto T; Maruo T
    Oncology; 1999 Oct; 57 Suppl 2():49-58. PubMed ID: 10545803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease in the level and mRNA expression of LH-RH and EGF receptors after treatment with LH-RH antagonist cetrorelix in DU-145 prostate tumor xenografts in nude mice.
    Lamharzi N; Halmos G; Jungwirth A; Schally AV
    Int J Oncol; 1998 Sep; 13(3):429-35. PubMed ID: 9683774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.